Shanghai Shen Lian Biomedical Corporation (688098.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.39B |
| Enterprise Value | 3.28B |
| P/E Ratio | -243.94 |
| PEG Ratio | -2.2 |
| Price/Sales Ratio | 13.66 |
| Price/Book Ratio | 2.66 |
| Enterprise/Revenue | 13.44 |
| Enterprise/EBITDA | 135.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.07 |
| Operating Margin | -0.09 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 288.27M |
| Revenue/Share | 0.67 |
| Gross Profit | 288.27M |
| EBITDA | 43.78M |
| Net Income | -19.09M |
| Diluted EPS | -0.05 |
Balance Sheet
| Total Cash | 83.29M |
| Total Cash/Share | 0.2 |
| Total Debt | 14.09M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4 |
| Book Value Per Share | 3.43 |
Price History
| 52-Week Change | 42.74 |
| 52-Week High | 17.57 |
| 52-Week Low | 6.09 |
| Moving Average 50 Days | 8.54 |
| Moving Average 200 Days | 9.31 |
Statistics
| Average Volume | 4.15M |
| Shares Outstanding | 410.64M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
